drugset / Trial / NCT01289327

Propofol Versus Midazolam+Alfentanil for Sedation During Bronchoscopy: Comparison by Cutaneous Carbon Dioxide Tension

NCT01289327

Completed 115 enrolled Rabin Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

Although propofol is a popular agent for sedation during flexible bronchoscopy, some clinicians have raised concerns that it may cause greater respiratory drive reduction than more common drugs. However, this factor is difficult to accurately examine with pulse oximetry. The introduction of a novel device that noninvasively measures carbon dioxide (CO2) levels can help to resolve this controversy. The aim of this study is to evaluate the safety of conscious sedation with midazolam+alfentanil compared to propofol.

Timeline

Start
2010-04
Primary completion
2010-11
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alfentanil Other / unclassified 0.5 mg Intravenous
Comparator Midazolam Small molecule 1 mg Intravenous
Comparator Midazolam Small molecule 3 mg Intravenous
Comparator Propofol Small molecule 10 mg Intravenous
Comparator Propofol Small molecule 20 mg Intravenous

Indications